Published in

Elsevier, Canadian Journal of Cardiology, 2(36), p. 159-169, 2020

DOI: 10.1016/j.cjca.2019.11.036

Links

Tools

Export citation

Search in Google Scholar

CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis

Journal article published in 2020 by Eileen O’Meara, Michael McDonald, Michael Chan, Anique Ducharme ORCID, Justin A. Ezekowitz, Nadia Giannetti, Adam Grzeslo, George A. Heckman, Jonathan G. Howlett, Sheri L. Koshman, Serge Lepage ORCID, Lisa M. Mielniczuk, Gordon W. Moe, Elizabeth Swiggum ORCID, Mustafa Toma and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO